Cargando…

Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy

Detalles Bibliográficos
Autores principales:	Kelderman, Sander, Heemskerk, Bianca, Toebes, Mireille, van Buuren, Marit, van Rooij, Nienke, Bies, Laura, Fanchi, Lorenzo, Germeroth, Lothar, Kvistborg, Pia, Schumacher, Ton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990297/ http://dx.doi.org/10.1186/2051-1426-1-S1-P19

Ejemplares similares

TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients
por: Kvistborg, Pia, et al.
Publicado: (2012)

Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
por: van den Berg, Joost H, et al.
Publicado: (2020)

High sensitivity of cancer exome-based CD8 T cell neo-antigen identification
por: van Buuren, Marit M, et al.
Publicado: (2014)

CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell Function
por: Sahillioglu, Ali Can, et al.
Publicado: (2021)

Flexible imputation of missing data
por: van Buuren, Stef
Publicado: (2018)

Fysikkpris til Fanamann
Publicado: (1981)

Petabytes til folket
Publicado: (2005)

Goldilocks and the three TILs
por: Dada, Hannah, et al.
Publicado: (2022)

Towards next‐generation TIL therapy: TILs enriched in neoepitope‐specific T cells
por: Arnaud, Marion, et al.
Publicado: (2023)

DFLpred: High-throughput prediction of disordered flexible linker regions in protein sequences
por: Meng, Fanchi, et al.
Publicado: (2016)

Development of a Hypersensitive Periodate-Cleavable Amino Acid that is Methionine- and Disulfide-Compatible and its Application in MHC Exchange Reagents for T Cell Characterisation
por: Amore, Alessia, et al.
Publicado: (2013)

Rejsen til universets indre
por: Kjaer, C
Publicado: (1998)

Blue Light Til Dawn/
por: Cassandra Wilson

Nedtelling til tidenes stjernesmell
Publicado: (2008)

Verden står til Jul
Publicado: (2009)

Long-distance modulation of bystander tumor cells by CD8(+) T cell-secreted IFNγ
por: Hoekstra, Mirjam E., et al.
Publicado: (2020)

PD-1(T) TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC
por: Hummelink, Karlijn, et al.
Publicado: (2022)

Comparative Study on the Larvicidal Activity of Drimane Sesquiterpenes and Nordrimane Compounds against Drosophila melanogaster til-til
por: Montenegro, Ivan, et al.
Publicado: (2013)

CERN-anlegg til to milliarder planglagt
por: Sundar, E
Publicado: (1964)

Pumpemotstand for vakuumkammer til CERN PS
Publicado: (1952)

Jaktar på gåtene til universet
por: Toft, Martin
Publicado: (2004)

Cern fik protoner til at kollidere
Publicado: (2009)

Klar til et langt år
Publicado: (2010)

Identification and characterization of a SARS-CoV-2 specific CD8(+) T cell response with immunodominant features
por: Gangaev, Anastasia, et al.
Publicado: (2021)

Intratumoral checkpoint subversion as a strategy for minimizing adverse effects: Harvesting the power of TILs without harvesting TILs
por: Alabanza, Leah, et al.
Publicado: (2014)

QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironment
por: Bresser, Kaspar, et al.
Publicado: (2022)

Reproducibility of Illumina platform deep sequencing errors allows accurate determination of DNA barcodes in cells
por: Beltman, Joost B., et al.
Publicado: (2016)

Teori om masseudslettelse vakt til live
por: Norgaard, H
Publicado: (1995)

En guide til utstillingen: hadroner for helse
por: Kienzle, Werner, et al.
Publicado: (1997)

Just one week 'til GridWorld
por: Harris, Derrick
Publicado: (2006)

Pengestøtte skal lokke studenter til CERN
por: Asphjell, Arne
Publicado: (2006)

Nedtælling til Big Bang 2.0
Publicado: (2008)

Cern tæller ned til Big Bang
Publicado: (2008)

Tissue Biomarkers in Melanoma Patients Treated with TIL
por: Knol, Anne-Chantal, et al.
Publicado: (2012)

Adoptive TIL in HPV-negative oral scca
por: Leidner, Rom, et al.
Publicado: (2015)

Lipids for CD8(+) TILs: Beneficial or harmful?
por: Wu, Duojiao, et al.
Publicado: (2022)

Immunohistochemical Markers and TILs Evaluation for Endometrial Carcinoma
por: Bounous, Valentina Elisabetta, et al.
Publicado: (2022)

Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions
por: Teng, Feifei, et al.
Publicado: (2016)

High post‐chemotherapy TIL and increased CD4+TIL are independent prognostic factors of surgically resected NSCLC following neoadjuvant chemotherapy
por: Jia, Wenxiao, et al.
Publicado: (2023)

Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness
por: Lindenberg, Melanie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kjb8hqn4qj7n1t5khb4gt1l98k